K
Power Law company profile
Kriya Therapeutics
Biotech & Life Sciences · Morrisville, United States · Founded 2019 Unicorn
Global footprint
Where Kriya Therapeutics has talent and traffic
AI talent share
1.0%
of workforce is AI talent
(2 of 195 staff)
(2 of 195 staff)
Core AI10.51%
Other AI10.51%
Non-AI workforce19398.97%
Web traffic by country
8.2K
monthly visits
across markets
across markets
🇺🇸 United States75.6%
🇮🇳 India13.4%
🇬🇧 United Kingdom7.3%
🇪🇸 Spain4.9%
Patent intelligence
$357k patent portfolio · 9 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$357k
0.02% of valuation · 2185.6× smaller than top peer BioNTech ($780M)
9 active patent families
Where Kriya Therapeutics innovates
Molecular biologyNucleic acid sequenceExpression cassettePromoterNucleic acid sequencing
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Kriya Therapeutics on the five Patsnap quality dimensions
Kriya Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Kriya Therapeutics concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Kriya Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Kriya Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.